These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1154 related articles for article (PubMed ID: 8710059)

  • 1. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
    Litvan I; Agid Y; Calne D; Campbell G; Dubois B; Duvoisin RC; Goetz CG; Golbe LI; Grafman J; Growdon JH; Hallett M; Jankovic J; Quinn NP; Tolosa E; Zee DS
    Neurology; 1996 Jul; 47(1):1-9. PubMed ID: 8710059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy.
    Respondek G; Roeber S; Kretzschmar H; Troakes C; Al-Sarraj S; Gelpi E; Gaig C; Chiu WZ; van Swieten JC; Oertel WH; Höglinger GU
    Mov Disord; 2013 Apr; 28(4):504-9. PubMed ID: 23436751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
    Shoeibi A; Litvan I; Juncos JL; Bordelon Y; Riley D; Standaert D; Reich SG; Shprecher D; Hall D; Marras C; Kluger B; Olfati N; Jankovic J
    Parkinsonism Relat Disord; 2019 Dec; 69():34-39. PubMed ID: 31665686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
    Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA
    Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
    Litvan I; Agid Y; Jankovic J; Goetz C; Brandel JP; Lai EC; Wenning G; D'Olhaberriague L; Verny M; Chaudhuri KR; McKee A; Jellinger K; Bartko JJ; Mangone CA; Pearce RK
    Neurology; 1996 Apr; 46(4):922-30. PubMed ID: 8780065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.
    Nath U; Ben-Shlomo Y; Thomson RG; Morris HR; Wood NW; Lees AJ; Burn DJ
    Brain; 2001 Jul; 124(Pt 7):1438-49. PubMed ID: 11408338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive supranuclear palsy in a sample of Brazilian population: clinical features of 16 patients.
    Carrilho PE; Barbosa ER
    Arq Neuropsiquiatr; 2002 Dec; 60(4):917-22. PubMed ID: 12563380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
    Tolosa E; Valldeoriola F; Marti MJ
    J Neural Transm Suppl; 1994; 42():15-31. PubMed ID: 7964684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history and clinical features of progressive supranuclear palsy: a clinical study.
    Diroma C; Dell'Aquila C; Fraddosio A; Lamberti S; Mastronardi R; Russo I; De Mari M; Iliceto G
    Neurol Sci; 2003 Oct; 24(3):176-7. PubMed ID: 14598074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability.
    Kurz C; Ebersbach G; Respondek G; Giese A; Arzberger T; Höglinger GU
    Acta Neuropathol Commun; 2016 Nov; 4(1):120. PubMed ID: 27842578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive supranuclear palsy: where are we now?
    Burn DJ; Lees AJ
    Lancet Neurol; 2002 Oct; 1(6):359-69. PubMed ID: 12849397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review.
    Tilley E; McLoughlin J; Koblar SA; Doeltgen SH; Stern C; White S; Peters MD
    JBI Database System Rev Implement Rep; 2016 Jun; 14(6):148-95. PubMed ID: 27532657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical heterogeneity in progressive supranuclear palsy: problems of clinical diagnostic criteria of NINDS-SPSP in a retrospective study of seven Japanese autopsy cases.
    Sakamoto R; Tsuchiya K; Mimura M
    Neuropathology; 2010 Feb; 30(1):24-35. PubMed ID: 19508347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
    Höglinger GU; Respondek G; Stamelou M; Kurz C; Josephs KA; Lang AE; Mollenhauer B; Müller U; Nilsson C; Whitwell JL; Arzberger T; Englund E; Gelpi E; Giese A; Irwin DJ; Meissner WG; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Antonini A; Bhatia KP; Bordelon Y; Compta Y; Corvol JC; Colosimo C; Dickson DW; Dodel R; Ferguson L; Grossman M; Kassubek J; Krismer F; Levin J; Lorenzl S; Morris HR; Nestor P; Oertel WH; Poewe W; Rabinovici G; Rowe JB; Schellenberg GD; Seppi K; van Eimeren T; Wenning GK; Boxer AL; Golbe LI; Litvan I;
    Mov Disord; 2017 Jun; 32(6):853-864. PubMed ID: 28467028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of a case and review of the literature].
    Trevisol-Bittencourt PC
    Arq Neuropsiquiatr; 1992 Sep; 50(3):369-74. PubMed ID: 1308417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): a short historical review.
    Pearce JM
    Neurologist; 2007 Sep; 13(5):302-4. PubMed ID: 17848869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).
    Hauw JJ; Daniel SE; Dickson D; Horoupian DS; Jellinger K; Lantos PL; McKee A; Tabaton M; Litvan I
    Neurology; 1994 Nov; 44(11):2015-9. PubMed ID: 7969952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.